Clin Exp Otorhinolaryngol.  2017 Dec;10(4):289-295. 10.21053/ceo.2016.01578.

Review of Heterotopic Thyroid Autotransplantation

• Sakr M
• Mahmoud A

• KMID: 2396781
• DOI: http://doi.org/10.21053/ceo.2016.01578

Abstract

Total thyroidectomy is increasingly accepted for the management of bilateral benign thyroid disorders. Postoperatively, patients require lifelong levothyroxine replacement therapy to avoid postoperative hypothyroidism, which besides the burden of compliance, has been proven to be associated with several long-term side effects. Heterotopic thyroid autotransplantation was proposed several decades ago to avoid the need for life-long postoperative replacement therapy with maintaining the autoregulatory mechanism of thyroxin production inside the body according to its needs. Available data regarding this topic in literature is relatively poor. Before applying thyroid autotransplantation on humans, several studies have been done on animals, where the autologous transplantations were found to be successful in almost all the cases, proved by follow up postoperative 8-week measurements of thyroid hormones and histopathological examination of the removed autografts. Regarding the clinical application, few trials have been done using cryopreserved in vivo, in vitro or immediately autotransplanted thyroid autografts. Satisfactory results were obtained, however, the number of these studies and the number of patients per each study was very low. Besides the study methodologies were not so consistent.

Keyword

Thyroid; Transplantation, Autologous; Transplantation, Heterotopic; Thyroidectomy; Review

MeSH Terms

Animals
Autografts*
Compliance
Follow-Up Studies
Humans
Hypothyroidism
In Vitro Techniques
Thyroid Gland*
Thyroid Hormones
Thyroidectomy
Thyroxine
Transplantation, Autologous*
Transplantation, Heterotopic
Thyroid Hormones
Thyroxine

Reference

1. Mishra A, Agarwal A, Agarwal G, Mishra SK. Total thyroidectomy for benign thyroid disorders in an endemic region. World J Surg. 2001; Mar. 25(3):307–10.

2. Bron LP, O’Brien CJ. Total thyroidectomy for clinically benign disease of the thyroid gland. Br J Surg. 2004; May. 91(5):569–74.

3. Arem R, Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism: effect of levothyroxine therapy. Arch Intern Med. 1990; Oct. 150(10):2097–100.

4. Althaus BU, Staub JJ, Ryff-De Leche A, Oberhansli A, Stahelin HB. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol (Oxf). 1988; Feb. 28(2):157–63.

5. Sethi MJ, Parr M, Bhatia V. Management strategies for hypothyroidism in non-compliant patients: a case report and review of literature. S D Med. 2008; Oct. 61(10):368–9.

6. Lips DJ, van Reisen MT, Voigt V, Venekamp W. Diagnosis and treatment of levothyroxine pseudomalabsorption. Neth J Med. 2004; Apr. 62(4):114–8.

7. Papaziogas B, Antoniadis A, Lazaridis Ch, Makris J, Kotakidou R, Paraskevas G, et al. Functional capacity of the thyroid autograft: an experimental study. J Surg Res. 2002; Apr. 103(2):223–7.

8. Wiersinga WM. Thyroid hormone replacement therapy. Horm Res. 2001; 56 Suppl 1:74–81.

9. Dong BJ, Hauck WW, Gambertoglio JG, Gee L, White JR, Bubp JL, et al. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. JAMA. 1997; Apr. 277(15):1205–13.

10. Bagattoli RM, Vaisman M, Lima JS, Ward LS. Estudo de adesao ao tratamento do hipotiroidismo. Arq Bras Endocrinol Metab. 2000; Dec. 44(6):483–7.

11. Stoffer SS, Szpunar WE. Potency of current levothyroxine preparations evaluated by high-performance liquid chromatography. Henry Ford Hosp Med J. 1988; 36(1):64–5.

12. Perros P. European Thyroid Association guidelines on L-t4+L-t3 combination for hypothyroidism: a weary step in the right direction. Eur Thyroid J. 2012; Jul. 1(2):51–4.

13. Langdahl BL, Loft AG, Moller N, Weeke J, Eriksen EF, Mosekilde L, et al. Skeletal responsiveness to thyroid hormone is not altered at menopause. Bone. 1996; Nov. 19(5):557–64.

14. Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol. 1994; Apr. 130(4):350–6.

15. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab. 1996; Dec. 81(12):4278–89.

16. Fatourechi V. Adverse effects of subclinical hyperthyroidism. Lancet. 2001; Sep. 358(9285):856–7.

17. Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, Cittadini A, et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 1999; Jun. 84(6):2064–7.

18. Monzani F, Caraccio N, Kozakowa M, Dardano A, Vittone F, Virdis A, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. J Clin Endocrinol Metab. 2004; May. 89(5):2099–106.

19. Meng R, Tang HY, Westfall J, London D, Cao JH, Mousa SA, et al. Crosstalk between integrin αvβ3 and estrogen receptor-α is involved in thyroid hormone-induced proliferation in human lung carcinoma cells. PLoS One. 2011; Nov. 6(11):e27547.

20. Yu X, Chen Y, Shan Z, Teng W, Li C, Zhou W, et al. The pattern of thyroid function of subclinical hypothyroid women with levothyroxine treatment during pregnancy. Endocrine. 2013; Dec. 44(3):710–5.

21. Centanni M. Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches. Endocrine. 2013; Feb. 43(1):8–9.

22. Centanni M, Gargano L, Canettieri G, Viceconti N, Franchi A, Delle Fave G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006; Apr. 354(17):1787–95.

23. Hays MT. Thyroid hormone and the gut. Endocr Res. 1988; 14(2-3):203–24.

24. Northcutt RC, Stiel JN, Hollifield JW, Stant EG Jr. The influence of cholestyramine on thyroxine absorption. JAMA. 1969; Jun. 208(10):1857–61.

25. Havrankova J, Lahaie R. Levothyroxine binding by sucralfate. Ann Intern Med. 1992; Sep. 117(5):445–6.

26. Shakir KM, Chute JP, Aprill BS, Lazarus AA. Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism. South Med J. 1997; Jun. 90(6):637–9.

27. Liel Y, Sperber AD, Shany S. Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide. Am J Med. 1994; Oct. 97(4):363–5.

28. Schneyer CR. Calcium carbonate and reduction of levothyroxine efficacy. JAMA. 1998; Mar. 279(10):750.

29. Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000; Jun. 283(21):2822–5.

30. De Luca F, Arrigo T, Pandullo E, Siracusano MF, Benvenga S, Trimarchi F. Changes in thyroid function tests induced by 2 month carbamazepine treatment in L-thyroxine-substituted hypothyroid children. Eur J Pediatr. 1986; Apr. 145(1-2):77–9.

31. Singh N, Hershman JM. Interference with the absorption of levothyroxine. Curr Opin Endocrinol Diabetes. 2003; Oct. 10(5):347–52.

32. Bell DS, Ovalle F. Use of soy protein supplement and resultant need for increased dose of levothyroxine. Endocr Pract. 2001; May-Jun. 7(3):193–4.

33. Deiana L, Marini S, Mariotti S. Ingestion of large amounts of papaya fruit and impaired effectiveness of levothyroxine therapy. Endocr Pract. 2012; Jan-Feb. 18(1):98–100.

34. Lilja JJ, Laitinen K, Neuvonen PJ. Effects of grapefruit juice on the absorption of levothyroxine. Br J Clin Pharmacol. 2005; Sep. 60(3):337–41.

35. Benvenga S, Bartolone L, Pappalardo MA, Russo A, Lapa D, Giorgianni G, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008; Mar. 18(3):293–301.

36. Halsted WS. Auto- and isotransplantation, in dogs, of the parathyroid glandules. J Exp Med. 1909; Jan. 11(1):175–99.

37. Walker RP, Paloyan E, Kelley TF, Gopalsami C, Jarosz H. Parathyroid autotransplantation in patients undergoing a total thyroidectomy: a review of 261 patients. Otolaryngol Head Neck Surg. 1994; Sep. 111(3 Pt 1):258–64.

38. Rabkin JM, Olyaei AJ, Orloff SL, Geisler SM, Wahoff DC, Hering BJ, et al. Distant processing of pancreas islets for autotransplantation following total pancreatectomy. Am J Surg. 1999; May. 177(5):423–7.

39. Nabishah BM, Khalid BA, Morat PB, Zanariyah A. Regeneration of adrenal cortical tissue after adrenal autotransplantation. Exp Clin Endocrinol Diabetes. 1998; 106(5):419–24.

40. Barten EJ, Newling DW. Transplantation of the testis; from the past to the present. Int J Androl. 1996; Aug. 19(4):205–11.

41. Callejo J, Jauregui MT, Valls C, Fernandez ME, Cabre S, Lailla JM. Heterotopic ovarian transplantation without vascular pedicle in syngeneic Lewis rats: six-month control of estradiol and folliclestimulating hormone concentrations after intraperitoneal and subcutaneous implants. Fertil Steril. 1999; Sep. 72(3):513–7.

42. Chernozemski I, Christov K. Autotransplantation and homotransplantation of thyroid gland in the hamster cheek pouch. Nature. 1967; Jul. 215(5096):70.

43. Nagamine S. Experimental studies on the autotransplantation of thyroid gland using micro-vascular anastomoses. Nihon Geka Hokan. 1968; Jan. 37(1):32–57.

44. Yamane I, Kamba S. Autotransplantation of the thyroid in the bone marrow and the vascular lumen. Yonago Acta Med. 1970; Dec. 14(3):131–45.

45. Raaf JH, Van Pilsum JF, Good RA. Fresh and cultured thyroid gland: survival and function after implantation. Ann Surg. 1976; Feb. 183(2):146–56.

46. Shimizu K, Nagahama M, Kitamura Y, Igarashi T, Aida N, Tanaka S. Improvement of thyroid function after autotransplantation of cryopreserved thyroid tissues in rats: clinical application of the procedure to patients with persistent hypothyroid Graves’ disease after thyroidectomy. Thyroidol Clin Exp. 1996; 8:55–62.

47. Pasteur IP, Tronko ND, Drozdovich II, Turchin IS, Balla IA. Thyroid transplantation: possibility of application for the treatment of persistent hypothyroidism and study of mechanisms of interaction between graft and hypothalamic-pituitary axis of recipient. In : Kitagawa Y, Matsuda T, Iijima S, editors. Animal cell technology: basic & applied aspects. vol. 10. Dordrecht, Netherlands: Kluwer Academic Publishers;1999. p. 289–93.

48. Gal I, Miko I, Furka I, Nagy D. Autotransplantation of cryopreserved thyroid tissue in dogs. Magy Seb. 2005; Apr. 58(2):93–9.

49. Dobrinja C, Trevisan R, Trevisan G, Liguori G. Autotransplantation of thyroid tissue in rats: an experimental study. Ann Ital Chir. 2008; Sep-Oct. 79(5):389–95.

50. Karaman M, Tuncel A, Sheidaei S, Karabulut MH, Tatlıpınar A. Functional capacity of the thyroid autograft and heterograft: an experimental study. Head Neck. 2012; May. 34(5):702–8.

51. Minuto FM, Fazzuoli L, Rollandi GA, Derchi LE, Biassoni P. Successful autotransplantation of lingual thyroid: 37-year follow-up. Lancet. 1995; Sep. 346(8979):910.

52. Sheverdin IuP. The results of a 15-year observation of patients with an autotransplant of thyroid gland fragments performed to prevent postoperative hypothyroidism. Vestn Khir Im I I Grek. 1992; Feb. 148(2):152–6.

53. Pushkar’ NS, Makedonskaia VA, Utevskii AM, Chuiko VA, Karpenko LG. Autoimplantation of cryopreserved (-196 degrees C) thyroid gland parenchyma as a treatment method in postoperative hypothyroidism. Probl Endokrinol (Mosk). 1984; Sep-Oct. 30(5):42–6.

54. Okamoto T, Fujimoto Y, Obara T, Ito Y, Kodama T, Kusakabe K. Trial of thyroid autotransplantation in patients with Graves’ disease whose remnant thyroid has unintentionally been made too small at subtotal thyroidectomy. Endocrinol Jpn. 1990; Feb. 37(1):95–101.

55. Shimizu K, Kitamura Y, Nagahama M, Shoji T. A fundamental study of the thyroid transplantation for the patient with irreversible hypothyroidism (the first report: an autotransplantation of cryopreserved thyroid): preliminary report. Nihon Geka Gakkai Zasshi. 1991; Dec. 92(12):1728.

56. Shimizu K, Kumita S, Kitamura Y, Nagahama M, Kitagawa W, Akasu H, et al. Trial of autotransplantation of cryopreserved thyroid tissue for postoperative hypothyroidism in patients with Graves’ disease. J Am Coll Surg. 2002; Jan. 194(1):14–22.

57. Roy PG, Saund MS, Thusoo TK, Roy D, Sankar R. Fate of human thyroid tissue autotransplants. Surg Today. 2003; 33(8):571–6.

58. Mohsen AA, Nada AA, Ibrahim MY, Ghaleb AH, Abou-Gabal MA, Mohsen AA, et al. Technique and outcome of autotransplanting thyroid tissue after total thyroidectomy for simple multinodular goiters. Asian J Surg. 2017; Jan. 40(1):17–22.

59. Saleh AM. Survival and functional capacity of heterotopic thyroid autograft after total thyroidectomy for benign goiters [dissertation]. Alexandria, Egypt: Faculty of Medicine, Alexandria University;2016.